Interpharm(OTC) IPAH

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals. The company offers both prescription-strength and over-the-counter products, serving a diverse clientele including retail chains and healthcare organizations.

Products and Services

• Generic pharmaceuticals for prescription and over-the-counter use
• Manufacturing capabilities for a wide range of medicinal products
• Distribution services to retail chains and healthcare organizations

Growth Outlook

• Established in 1984, with a long history in the pharmaceutical industry
• Potential for expansion in the growing generic drug market
• Focus on increasing distribution networks across the U.S.

Financial Highlights

• Recent quarterly revenue of $16.2 million, showing market demand
• Trailing twelve months (TTM) gross profit margin of 28.66%
• Current ratio of 1.05 indicates adequate short-term financial health

Interpharm Holdings, Inc. has positioned itself as a key player in the generic pharmaceuticals sector, leveraging its extensive experience and established distribution channels. The company's recent revenue figures reflect a solid demand for its products, while the gross profit margin indicates effective cost management. The current ratio suggests that the company is capable of meeting its short-term obligations, which is a positive sign for potential investors. With a focus on expanding its market presence and enhancing distribution capabilities, Interpharm Holdings, Inc. presents an intriguing opportunity in the healthcare sector.